Vani Bharani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vani Bharani has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Pankaj Malhotra
Department of Clinical Hematology and Medical Oncology Postgraduate Institute of Medical Education and Research Chandigarh India
2 shared publications - Arun Elangovan
Department of Radiation Oncology, Cross Cancer Institute, 11560 University Avenue, Edmonton, AB T6G 1Z2, Canada
1 shared publication - Bharti Bharani
Dysplasia Clinic
1 shared publication - Chinna Babu Dracham
Department of Radiotherapy and Oncology, PGIMER, Chandigarh, India
1 shared publication - Lokeswari Annam1 shared publication
- Neelam Varma
Department of Hematology Post Graduate Institute of Medical Education and Research Chandigarh India
1 shared publication
Latest Publications
- Open Access
- 27 October 2020
- Published by Global Journals in Global Journal of Medical Research
- p. 13-16
Primary Transitional Cell Carcinoma of Fallopian Tube: A Rare Entity with Review of Literature
Objective: Primary fallopian tube carcinoma (PFTC) is a rare entity constituting only 0.2-1.5% of all primary female genital-tract malignancies. Transitional cell carcinoma of fallopian tube is very rare constituting only around 10% of the PFTC and very less literature have been reported worldwide. Case report: A 59-year-old postmenopausal women presented with discharge per vaginum and abdominal distension, and was found to have right adnexal mass on clinical examination. Imaging findings were suggestive of a heterogenous adnexal mass and she underwent staging laparotomy. Post-operative histopathology examination confirmed a primary transitional cell carcinoma of right fallopian tube. FIGO stage was IA, and she received six cycles of adjuvant chemotherapy. The patient is now alive, after 10-years of initial treatment.
- 27 October 2020
- Published by Global Journals in Global Journal of Medical Research
- p. 13-16
Open AccessPrimary Transitional Cell Carcinoma of Fallopian Tube: A Rare Entity with Review of Literature
Objective: Primary fallopian tube carcinoma (PFTC) is a rare entity constituting only 0.2-1.5% of all primary female genital-tract malignancies. Transitional cell carcinoma of fallopian tube is very rare constituting only around 10% of the PFTC and very less literature have been reported worldwide. Case report: A 59-year-old postmenopausal women presented with discharge per vaginum and abdominal distension, and was found to have right adnexal mass on clinical examination. Imaging findings were suggestive of a heterogenous adnexal mass and she underwent staging laparotomy. Post-operative histopathology examination confirmed a primary transitional cell carcinoma of right fallopian tube. FIGO stage was IA, and she received six cycles of adjuvant chemotherapy. The patient is now alive, after 10-years of initial treatment.
- 6 April 2018
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 34 (4) , 742-744
Diffuse Large B Cell Lymphoma with Pseudoacinar Arrangement: A Potential Diagnostic Pitfall
- 6 April 2018
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 34 (4) , 742-744
Diffuse Large B Cell Lymphoma with Pseudoacinar Arrangement: A Potential Diagnostic Pitfall
- 31 January 2018
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 34 (4) , 632-635
Excess Free Light Chains in Serum Immunofixation Electrophoresis: Attributes of a Distinctive Pattern
Serum and urine protein electrophoresis and immunofixation are essential for identification and categorization of M protein/monoclonal protein. Based on the number of discrete bands identified the condition can be a monoclonal, biclonal or triclonal gammopathy. A subset of cases show an interesting pattern on immunofixation electrophoresis, with a complete immunoglobulin molecule, along with excess free light chains where in one light chain band shows similar mobility as the heavy chain, while the other light chain band of same isotype has a different mobility. Over a 3 year study period, 420 immunofixation electrophoresis gels were studied to select the cases with the typical pattern as described. The clinical records where searched for data of baseline evaluations done prior to starting therapy, including clinical presentation, biochemical parameters, hemogram and bone marrow examination. Twenty cases (4.7%) were identified from the records, of these 77.8% cases had renal impairment and 33.3% presented with rapidly progressive renal failure. The possible explanation is the toxic effects of excess free light chains, in our cohort. The bound LCs show mobility similar to the HC bands on serum immunofixation gels, however the free light chains, exist in polymeric forms and show a different mobility. The identification and reporting of this pattern provides additional information regarding the high load of light chains, and indicates that patient may have a poor renal outcome/performance.
- 31 January 2018
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 34 (4) , 632-635
Excess Free Light Chains in Serum Immunofixation Electrophoresis: Attributes of a Distinctive Pattern
Serum and urine protein electrophoresis and immunofixation are essential for identification and categorization of M protein/monoclonal protein. Based on the number of discrete bands identified the condition can be a monoclonal, biclonal or triclonal gammopathy. A subset of cases show an interesting pattern on immunofixation electrophoresis, with a complete immunoglobulin molecule, along with excess free light chains where in one light chain band shows similar mobility as the heavy chain, while the other light chain band of same isotype has a different mobility. Over a 3 year study period, 420 immunofixation electrophoresis gels were studied to select the cases with the typical pattern as described. The clinical records where searched for data of baseline evaluations done prior to starting therapy, including clinical presentation, biochemical parameters, hemogram and bone marrow examination. Twenty cases (4.7%) were identified from the records, of these 77.8% cases had renal impairment and 33.3% presented with rapidly progressive renal failure. The possible explanation is the toxic effects of excess free light chains, in our cohort. The bound LCs show mobility similar to the HC bands on serum immunofixation gels, however the free light chains, exist in polymeric forms and show a different mobility. The identification and reporting of this pattern provides additional information regarding the high load of light chains, and indicates that patient may have a poor renal outcome/performance.
- Open Access
- 1 May 2017
- Published by Elsevier in Indian Heart Journal
- Vol. 69 (3) , 325-327
Evaluation of gamma glutamyl transferase as a marker of cardiovascular risk, in 200 angiographically proven coronary artery disease patients
- 1 May 2017
- Published by Elsevier in Indian Heart Journal
- Vol. 69 (3) , 325-327
Open AccessEvaluation of gamma glutamyl transferase as a marker of cardiovascular risk, in 200 angiographically proven coronary artery disease patients
- 2 February 2017
- Published by Springer Nature
- p. 43-60
Cytology as a Screening Tool